3 FTSE Shares Hitting New Highs: Ashtead Group plc, AstraZeneca plc And easyJet plc

Ashtead Group plc (LON: AHT), AstraZeneca plc (LON: AZN) and easyJet plc (LON: EZJ) head up and up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So, did you think yesterday’s 82-point rise for the FTSE 100 (FTSEINDICES: ^FTSE) to 6,522 points signaled the start of a recovery? Well, think again — the index of top UK shares has already dipped back below 6,500, dropping 27 points to 6,495 by mid-morning. The punters appear to be nervous ahead of Wednesday’s US Federal Reserve decision on its economic policies, with many fearing recent upbeat US data will lead to an earlier-than-expected cutback in bond buying.

But even if the FTSE is a long way from breaking records, at least some individual shares are managing it. Here are three that are reaching new heights:

Ashtead

Ashtead Group (LSE: AHT) shares hit their highest closing price for 52 weeks yesterday, reaching 754.5p for a 12-month gain of more than 80% — and as I write, the price is unmoved from that level.

The equipment-rental firm reported impressive first-half results last week, with revenue up 23% and underlying pre-tax profit up a very nice 49%. Underlying earnings per share gained 50%, enabling the company to hike its interim dividend by a similar 50% to 2.25p per share.

The climb in Ashtead’s share price during 2013 has come at a cost, and there’s now a forward P/E based on current forecasts of nearly 18. That’s a tad higher then the FTSE average of around 14, and dividend yields are only around 1.4%. But there’s more EPS growth expected, with 2015 forecasts bringing the P/E down to 15.

AstraZeneca

AstraZeneca (LSE: AZN) (NYSE: AZN.US) also hit a new 52-week closing high yesterday, ending the day at 3,547.5p.

Today the price has fallen back a little to 3,532p, but that still leaves it more than 20% up over the past 12 months — and that’s not bad going for a FTSE 100 giant, especially when the index itself has managed less than half that.

AstraZeneca’s Q3 update was met with a favourable response from the market, and since then the firm has enjoyed good results from a couple of new drugs — an FDA Advisory Committee approval for one, and a successful Phase III trial for another.

easyJet

easyJet (LSE: EZJ) shares just won’t stop climbing — they have now more than doubled to reach a record close of 1,506p yesterday, and today the price is a quarter of a penny higher.

And even after such a dramatic rise, the shares are still only on a forward P/E of 14 — although some would say that’s too high, given the risky nature of airlines which are so critically dependent on fuel costs.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares mentioned in this article.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »

Google office headquarters
Investing Articles

A dividend announcement sends the Alphabet share price soaring. Here’s what investors need to know

As the Alphabet share price surges on the announcement of a dividend, Stephen Wright outlines what investors should really be…

Read more »